Romagne; Francois
Patent Applications and Registrations
Patent applications and USPTO patent grants for Romagne; Francois.The latest application filed is for "recognition tags for tgase-mediated conjugation".
Company Profile
6.27.38
- Romagne; Francois - Marseilles FR
- Romagne; Francois - Marseille FR
- Romagne; Francois - La Ciotat FR
Patent Activity
| Patent | Date |
|---|---|
| Enzymatic conjugation of antibodies Grant 10,675,359 - Dennler , et al. | 2020-06-09 |
| Enzymatic conjugation of polypeptides Grant 10,434,180 - Bregeon , et al. O | 2019-10-08 |
| Recognition Tags For Tgase-mediated Conjugation App 20190169601 - Fischer; Eliane ; et al. | 2019-06-06 |
| Monoclonal Antibodies Against Nkg2a App 20190135938 - Moretta; Alessandro ; et al. | 2019-05-09 |
| Anti-KIR combination treatments and methods Grant 10,253,095 - Romagne , et al. | 2019-04-09 |
| Monoclonal antibodies against NKG2A Grant 10,160,810 - Moretta , et al. Dec | 2018-12-25 |
| Screening of conjugated antibodies Grant 10,132,799 - Belmant , et al. November 20, 2 | 2018-11-20 |
| Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Grant 10,059,765 - Velardi , et al. August 28, 2 | 2018-08-28 |
| Recognition tags for TGase-mediated conjugation Grant 10,036,010 - Fischer , et al. July 31, 2 | 2018-07-31 |
| Enzymatic Conjugation Of Antibodies App 20180193476 - Dennler; Patrick ; et al. | 2018-07-12 |
| Enzymatic Conjugation Of Polypeptides App 20180071402 - Bregeon; Delphine ; et al. | 2018-03-15 |
| Enzymatic conjugation of antibodies Grant 9,764,038 - Dennler , et al. September 19, 2 | 2017-09-19 |
| Enzymatic conjugation of polypeptides Grant 9,717,803 - Bregeon , et al. August 1, 2 | 2017-08-01 |
| Enzymatic Conjugation Of Polypeptides App 20160331842 - Bregeon; Delphine ; et al. | 2016-11-17 |
| Compositions and methods for treating proliferative disorders Grant 9,447,185 - Romagne , et al. September 20, 2 | 2016-09-20 |
| Enzymatic conjugation of polypeptides Grant 9,427,478 - Bregeon , et al. August 30, 2 | 2016-08-30 |
| Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies Grant 9,333,255 - Wagtmann , et al. May 10, 2 | 2016-05-10 |
| Anti-kir Antibodies For The Treatment Of Inflammatory And Autoimmune Disorders App 20150376275 - Romagne; Francois ; et al. | 2015-12-31 |
| Screening Of Conjugated Antibodies App 20150346195 - Belmant; Christian ; et al. | 2015-12-03 |
| Human Anti-kir Antibodies App 20150344576 - Moretta; Alessandro ; et al. | 2015-12-03 |
| Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds App 20150299319 - Velardi; Andrea ; et al. | 2015-10-22 |
| Recognition Tags For Tgase-mediated Conjugation App 20150284713 - Fischer; Eliane ; et al. | 2015-10-08 |
| Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Grant 9,090,876 - Velardi , et al. July 28, 2 | 2015-07-28 |
| Human Anti-kir Antibodies App 20150191547 - Moretta; Alessandro ; et al. | 2015-07-09 |
| Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders Grant 9,067,997 - Romagne , et al. June 30, 2 | 2015-06-30 |
| Enzymatic Conjugation Of Polypeptides App 20150165064 - Bregeon; Delphine ; et al. | 2015-06-18 |
| Monoclonal Antibodies Against Nkg2a App 20150132316 - MORETTA; ALESSANDRO ; et al. | 2015-05-14 |
| Monoclonal Antibodies Against Nkg2a App 20150125464 - MORETTA; ALESSANDRO ; et al. | 2015-05-07 |
| Monoclonal antibodies against NKG2A Grant 8,993,319 - Moretta , et al. March 31, 2 | 2015-03-31 |
| Human anti-KIR antibodies Grant 8,981,065 - Moretta , et al. March 17, 2 | 2015-03-17 |
| Enzymatic Conjugation Of Antibodies App 20140356385 - Dennler; Patrick ; et al. | 2014-12-04 |
| Compositions and Methods for Treating Viral Infection App 20140023646 - Reumert WAGTMANN; Peter Andreas, Nicolai, ; et al. | 2014-01-23 |
| Nucleic acids encoding human anti-kir antibodies Grant 8,614,307 - Moretta , et al. December 24, 2 | 2013-12-24 |
| Human Anti-kir Anitbodies App 20130287770 - Moretta; Alessandro ; et al. | 2013-10-31 |
| Methods of treating viral infections by administering KIR2DL-binding antibodies Grant 8,551,483 - Wagtmann , et al. October 8, 2 | 2013-10-08 |
| Enzymatic Conjugation Of Polypeptides App 20130189287 - Bregeon; Delphine ; et al. | 2013-07-25 |
| Anti-kir Antibodies For The Treatment Of Inflammatory And Autoimmune Disorders App 20120328615 - Romagne; Francois ; et al. | 2012-12-27 |
| Human Anti-kir Antibodies App 20120208237 - Moretta; Alessandro ; et al. | 2012-08-16 |
| Human anti-KIR antibodies Grant 8,119,775 - Moretta , et al. February 21, 2 | 2012-02-21 |
| Anti-kir Combination Treatments And Methods App 20110293561 - ROMAGNE; FRANCOIS ; et al. | 2011-12-01 |
| Monoclonal Antibodies Against NKG2A App 20110229486 - Moretta; Allessandro ; et al. | 2011-09-22 |
| Transgenic Animals And Methods Of Making Recombinant Antibodies App 20110185441 - Romagne; Francois ; et al. | 2011-07-28 |
| Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds App 20110008335 - Velardi; Andrea ; et al. | 2011-01-13 |
| Compositions and Methods for Regulating an Immune Response in a Subject App 20100254940 - Romagne; Francois ; et al. | 2010-10-07 |
| Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds Grant 7,803,376 - Velardi , et al. September 28, 2 | 2010-09-28 |
| Monoclonal Antibodies Against Nkg2a App 20090208416 - Moretta; Alessandro ; et al. | 2009-08-20 |
| Anti-Kir Combination Treatments and Methods App 20090196850 - Romagne; Francois ; et al. | 2009-08-06 |
| Human Anti-Kir Antibodies App 20090081240 - Moretta; Alessandro ; et al. | 2009-03-26 |
| Compositions and Methods for Treating Viral Infection App 20090035305 - Wagtmann; Peter Andreas ; et al. | 2009-02-05 |
| Compositions and Methods for Treating Proliferative Disorders App 20080274047 - Romagne; Francois ; et al. | 2008-11-06 |
| Transgenic Animals and Methods of Making Recombinant Antibodies App 20080196112 - Romagne; Francois ; et al. | 2008-08-14 |
| Pharmaceutical Compositions Having an Effect on the Proliferation of Nk Cells and a Method Using the Same App 20080063717 - Romagne; Francois ; et al. | 2008-03-13 |
| Compositions and Methods for Treating Proliferative Disorders Such as Nk-Type Ldgl App 20070231322 - Romagne; Francois ; et al. | 2007-10-04 |
| Compositions and methods for enhancing nk cell activity App 20070178106 - Romagne; Francois | 2007-08-02 |
| Composition and method for the treatment of carcinoma App 20070134273 - Romagne; Francois ; et al. | 2007-06-14 |
| Compositions and methods for regulating an immune response in a subject App 20060194755 - Romagne; Francois ; et al. | 2006-08-31 |
| Methods for producing gamma delta t cells App 20050196385 - Romagne, Francois ; et al. | 2005-09-08 |
| Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds App 20050037002 - Velardi, Andrea ; et al. | 2005-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 